Literature DB >> 9688578

Heterodimerization is mainly responsible for the dominant negative activity of amino-terminally truncated rat androgen receptor forms.

T Ikonen1, J J Palvimo, O A Jänne.   

Abstract

Rat androgen receptor (rAR) mutants devoid of the amino-terminal transactivation domain are able to behave as dominant negative regulators of wild-type rAR. To address the underlying mechanisms of the trans-dominant negative action, we have examined the roles of the DNA-binding domain (DBD) and the ligand-binding domain (LBD) in this process. Transactivation experiments in CV-1 cells complemented by electrophoretic mobility shift assays revealed that the dominant negative receptor forms repress the function of wild-type rAR mainly through heterodimer formation, rather than through competition for binding to cognate DNA elements. Heterodimerization of receptor forms containing LBDs may take place even in the absence of specific DNA binding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688578     DOI: 10.1016/s0014-5793(98)00701-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Androgen receptor repression of GnRH gene transcription.

Authors:  Melissa J Brayman; Patricia A Pepa; Sara E Berdy; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Androgen receptor repression of gonadotropin-releasing hormone gene transcription via enhancer 1.

Authors:  Melissa J Brayman; Patricia A Pepa; Pamela L Mellon
Journal:  Mol Cell Endocrinol       Date:  2012-08-02       Impact factor: 4.102

3.  Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; Sankar N Maity; Yu-Chen Lee; Renata Ferrarotto; Julian C Post; Lisa Licitra; Scott M Lippman; Merrill S Kies; Randal S Weber; Carlos Caulin; Sue-Hwa Lin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

4.  The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1.

Authors:  C L Bevan; S Hoare; F Claessens; D M Heery; M G Parker
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

5.  Androgens, progestins, and glucocorticoids induce follicle-stimulating hormone beta-subunit gene expression at the level of the gonadotrope.

Authors:  Varykina G Thackray; Shauna M McGillivray; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2006-05-04

6.  Synergistic induction of follicle-stimulating hormone beta-subunit gene expression by gonadal steroid hormone receptors and Smad proteins.

Authors:  Varykina G Thackray; Pamela L Mellon
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

7.  Glucocorticoids induce human glycoprotein hormone alpha-subunit gene expression in the gonadotrope.

Authors:  Ravid Sasson; Sang H Luu; Varykina G Thackray; Pamela L Mellon
Journal:  Endocrinology       Date:  2008-04-10       Impact factor: 4.736

8.  A human FSHB promoter SNP associated with low FSH levels in men impairs LHX3 binding and basal FSHB transcription.

Authors:  Courtney A Benson; Troy L Kurz; Varykina G Thackray
Journal:  Endocrinology       Date:  2013-06-13       Impact factor: 4.736

Review 9.  N-terminal truncations in sex steroid receptors and rapid steroid actions.

Authors:  Derek A Schreihofer; Phong Duong; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-11-10       Impact factor: 2.668

10.  Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.

Authors:  Mark A Titus; Brian Zeithaml; Boris Kantor; Xiangping Li; Karin Haack; Dominic T Moore; Elizabeth M Wilson; James L Mohler; Tal Kafri
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.